These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34539628)

  • 1. Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 Trial.
    Shindiapina P; Pietrzak M; Seweryn M; McLaughlin E; Zhang X; Makowski M; Ahmed EH; Schlotter S; Pearson R; Kitzler R; Mozhenkova A; Le-Rademacher J; Little RF; Akpek G; Ayala E; Devine SM; Kaplan LD; Noy A; Popat UR; Hsu JW; Morris LE; Mendizabal AM; Krishnan A; Wachsman W; Williams N; Sharma N; Hofmeister CC; Forman SJ; Navarro WH; Alvarnas JC; Ambinder RF; Lozanski G; Baiocchi RA
    Front Immunol; 2021; 12():700045. PubMed ID: 34539628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.
    Alvarnas JC; Le Rademacher J; Wang Y; Little RF; Akpek G; Ayala E; Devine S; Baiocchi R; Lozanski G; Kaplan L; Noy A; Popat U; Hsu J; Morris LE; Thompson J; Horowitz MM; Mendizabal A; Levine A; Krishnan A; Forman SJ; Navarro WH; Ambinder R
    Blood; 2016 Aug; 128(8):1050-8. PubMed ID: 27297790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Proliferating Regulatory T Cells Post-Transplantation Are Associated with Poor Survival in Lymphoma Patients Treated with Autologous Hematopoietic Stem Cell Transplantation.
    Sumransub N; Cao Q; Wangen R; Brunstein C; Miller JS; Bachanova V
    Transplant Cell Ther; 2022 Apr; 28(4):184.e1-184.e8. PubMed ID: 35081473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.
    Herr MM; Torka P; Zhang Y; Wallace PK; Tario JD; Repasky EA; Chen GL; Ho CM; Balderman SR; Ross M; Paiva B; Hernandez-Ilizaliturri FJ; McCarthy PL; Hahn T
    Bone Marrow Transplant; 2020 Jan; 55(1):77-85. PubMed ID: 31227776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplified validated prognostic model for progression-free survival after autologous transplantation for hodgkin lymphoma.
    Hahn T; McCarthy PL; Carreras J; Zhang MJ; Lazarus HM; Laport GG; Montoto S; Hari PN
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1740-4. PubMed ID: 24096096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients.
    Lutfi F; Skelton Iv WP; Wang Y; Rosenau E; Farhadfar N; Murthy H; Cogle CR; Brown R; Hiemenz J; Wingard JR; Norkin M
    Hematol Oncol Stem Cell Ther; 2020 Mar; 13(1):23-31. PubMed ID: 31629722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
    Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with Lymphoma.
    Merryman RW; Redd R; Jeter E; Wong JL; McHugh K; Reynolds C; Nazzaro M; Varden A; Brown JR; Crombie JL; Davids MS; Fisher DC; Jacobsen E; Jacobson CA; Kim AI; LaCasce AS; Ng SY; Odejide OO; Parry EM; Dahi PB; Nieto Y; Joyce RM; Chen YB; Herrera AF; Armand P; Ritz J
    Transplant Cell Ther; 2022 Jan; 28(1):32.e1-32.e10. PubMed ID: 34670169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Finding the Optimal Conditioning Regimen for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Hematopoietic Cell Transplantation: A Retrospective Comparison of BEAM and High-Dose ICE.
    Esbah O; Tekgündüz E; Şirinoğlu Demiriz I; Civriz Bozdağ S; Kaya A; Tetik A; Kayıkçı Ö; Durgun G; Kocubaba Ş; Altuntaş F
    Turk J Haematol; 2016 Sep; 33(3):209-15. PubMed ID: 26377357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma.
    Tuazon SA; Cassaday RD; Gooley TA; Sandmaier BM; Holmberg LA; Smith SD; Maloney DG; Till BG; Martin DB; Chow VA; Rajendran JG; Fisher DR; Matesan MC; Lundberg SJ; Green DJ; Pagel JM; Press OW; Gopal AK
    Transplant Cell Ther; 2021 Jan; 27(1):57.e1-57.e8. PubMed ID: 32980545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation.
    Khouri J; Rybicki L; Majhail NS; Kalaycio M; Pohlman B; Hill B; Jagadeesh D; Dean R; Hamilton B; Sobecks R; Koo A; Liu H
    J Clin Apher; 2019 Dec; 34(6):638-645. PubMed ID: 31381194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.
    Savani M; Gencturk M; Shanley R; Cayci Z; Wilke C; Warlick ED; He F; Janakiram M; Weisdorf DJ; Brunstein CG; Bachanova V
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):272-277. PubMed ID: 31669174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.
    Johnston LJ; Stockerl-Goldstein KE; Hu WW; Negrin RS; Hoppe RT; Blume KG; Horning SJ
    Biol Blood Marrow Transplant; 2000; 6(5A):555-62. PubMed ID: 11071261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a Multicenter Phase II Trial of Brentuximab Vedotin as Second-Line Therapy before Autologous Transplantation in Relapsed/Refractory Hodgkin Lymphoma.
    Chen R; Palmer JM; Martin P; Tsai N; Kim Y; Chen BT; Popplewell L; Siddiqi T; Thomas SH; Mott M; Sahebi F; Armenian S; Leonard J; Nademanee A; Forman SJ
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2136-2140. PubMed ID: 26211987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.
    Chen YB; Lane AA; Logan B; Zhu X; Akpek G; Aljurf M; Artz A; Bredeson CN; Cooke KR; Ho VT; Lazarus HM; Olsson R; Saber W; McCarthy P; Pasquini MC
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1046-1053. PubMed ID: 25687795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.
    Chen AI; McMillan A; Negrin RS; Horning SJ; Laport GG
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):741-7. PubMed ID: 18541192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered thymic CD4
    Roussel X; Daguindau E; Berceanu A; Desbrosses Y; Saas P; Ferrand C; Seilles E; Pouthier F; Deconinck E; Larosa F
    Curr Res Transl Med; 2019 Nov; 67(4):135-143. PubMed ID: 31164285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Reconstitution Profiling Suggests Antiviral Protection after Transplantation with Omidubicel: A Phase 3 Substudy.
    Szabolcs P; Mazor RD; Yackoubov D; Levy S; Stiff P; Rezvani A; Hanna R; Wagner J; Keating A; Lindemans CA; Karras N; McGuirk J; Hamerschlak N; López-Torija I; Sanz G; Valcarcel D; Horwitz ME
    Transplant Cell Ther; 2023 Aug; 29(8):517.e1-517.e12. PubMed ID: 37120136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent thymic emigrants in lymphoma patients with and without human immunodeficiency virus infection candidates for autologous peripheral stem cell transplantation.
    Pratesi C; Simonelli C; Zanussi S; Talamini R; Bortolin MT; Tedeschi R; Marus A; Caffau C; Michieli M; Tirelli U; De Paoli P
    Clin Exp Immunol; 2008 Jan; 151(1):101-9. PubMed ID: 17931391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron Emission Tomography-Based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin Lymphoma.
    Procházka V; Gawande RS; Cayci Z; Froelich JW; Cao Q; Wilke C; Dusenbery K; Weisdorf DJ; Bachanova V
    Biol Blood Marrow Transplant; 2018 Jan; 24(1):64-70. PubMed ID: 28942016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.